Related Experiment Videos
Qualitative differences among cancer clinical trial explanations
1Department of Communication, Purdue University, West Lafayette, IN 47907, USA. froberts@purdue.edu
Social Science & Medicine (1982)
|October 31, 2002
Summary
Medical oncologists present breast cancer clinical trial options differently. One approach emphasizes local collaboration and downplays uncertainty, while another highlights national research and acknowledges randomization
Area of Science:
- Oncology
- Medical Ethics
- Communication in Healthcare
Background:
- Patient recruitment for experimental cancer treatments relies on effective communication.
- Understanding how oncologists present clinical trial options is crucial for informed consent.
- Variability in physician communication styles may impact patient enrollment decisions.
Purpose of the Study:
- To examine and compare how medical oncologists present experimental treatment trial options to breast cancer patients.
- To analyze the discourse practices used in recruiting patients for clinical trials in the United States.
Main Methods:
- A case study approach was employed.
- Two contrasting presentations of clinical trial options by physicians were compared.
- Analysis focused on the discourse and framing used in patient-physician interactions.
Main Results:
- Physician presentations of clinical trial options vary significantly.
- One presentation framed trials as local, collaborative efforts, minimizing uncertainty.
- A second presentation emphasized national research context and acknowledged randomization uncertainty.
Conclusions:
- Physician communication strategies for clinical trials differ substantially.
- The framing of clinical trials influences how patients perceive participation and uncertainty.
- This study offers insights into the actual discourse practices of patient recruitment for experimental protocols.